Nosso grupo organiza mais de 3.000 Séries de conferências Eventos todos os anos nos EUA, Europa e outros países. Ásia com o apoio de mais 1.000 Sociedades e publica mais de 700 Acesso aberto Periódicos que contém mais de 50.000 personalidades eminentes, cientistas de renome como membros do conselho editorial.
Periódicos de acesso aberto ganhando mais leitores e citações
700 periódicos e 15 milhões de leitores Cada periódico está obtendo mais de 25.000 leitores
Dr. Tyurin Michael
A pharmaceutical company is developing a new drug candidate for the treatment of a chronic disease. One of the critical steps in drug development understands how the drug is metabolized in the body, which can impact its efficacy and safety.
The company needs to analyze the metabolic pathways and identify metabolites produced when the drug is administered to living organisms.
They employ liquid chromatography-mass spectrometry (LC-MS), a powerful technique that combines separation capabilities of chromatography with the mass analysis capabilities of mass spectrometry. LC-MS allows them to separate and quantify different metabolites formed during drug metabolism.
By using LC-MS, the company identifies multiple metabolites produced in various organs, helping them understand the drug’s fate in the body. This knowledge guides further optimization of the drug’s structure and dosage, ensuring its effectiveness and safety.